FibroBiologics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $0.03 | $0.03 | $0.03 |
| Q2 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2024 | 1 | -$0.10 | -$0.07 | -$0.09 |
| Q1 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q4 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2026 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2026 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q1 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2027 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2027 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2027 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q1 2028 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2028 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2028 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q4 2028 | 1 | -$0.14 | -$0.14 | -$0.14 |
FibroBiologics, Inc. Common Stock Earnings Date And Information
FibroBiologics, Inc. Common Stock last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. FibroBiologics, Inc. Common Stock has generated $-1 earnings per share over the last year ($-0.68 diluted earnings per share) and currently has a price-to-earnings ratio of -4.9. FibroBiologics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
FibroBiologics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.08 | -$0.01 | 0.07 | $0 | $0 |
| 06/28/2024 | Q2 2024 | $0.03 | $0 | $0 | ||
| 03/30/2024 | Q1 2024 | -$0.26 | $0 | |||
| 12/30/2023 | Q4 2023 | -$0.34 | $0 | |||
| 09/29/2023 | Q3 2023 | -$0.07 | $0 | |||
| 06/29/2023 | Q2 2023 | -$0.07 | $0 | |||
| 03/30/2023 | Q1 2023 | -$0.07 | $0 | |||
| 12/30/2022 | Q4 2022 | -$0.05 | $0 | |||
| 09/28/2022 | Q3 2022 | -$0.05 | $0 |
FibroBiologics, Inc. Common Stock Earnings: Frequently Asked Questions
-
When is FibroBiologics, Inc. Common Stock's earnings date?
FibroBiologics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
How can I listen to FibroBiologics, Inc. Common Stock's earnings conference call?
The conference call for FibroBiologics, Inc. Common Stock's latest earnings report can be listened to online.
-
How can I read FibroBiologics, Inc. Common Stock's conference call transcript?
The conference call transcript for FibroBiologics, Inc. Common Stock's latest earnings report can be read online.
-
How much profit does FibroBiologics, Inc. Common Stock generate each year?
FibroBiologics, Inc. Common Stock (:FBLG) has a recorded net income of $0. FibroBiologics, Inc. Common Stock has generated $-0.59 earnings per share over the last four quarters.
-
What is FibroBiologics, Inc. Common Stock's price-to-earnings ratio?
FibroBiologics, Inc. Common Stock (:FBLG) has a price-to-earnings ratio of -4.9 and price/earnings-to-growth ratio is -0.63.
